23
Feb
Merck (NYSE:MRK) and Viralytics announced overnight the agreed acquisition of Viralytics by Merck for A$1.75 cash. The stock last traded at 63 cents prior to the announcement. VLA hit a high of $1.26 in December 2016.
22
Feb
Quest Asset Partners are a finalist in the Lonsec Fund Manager Awards for the second year in a row.
CONTACT US
Suite 807, 6A Glen Street
Milsons Point NSW 2061 Australia
Phone: 02 9409 2333
AFS Licence : 279 207